Nrf2 activator-1 is a potent activator of NF-E2 related factor 2 ( Nrf2 ). Nrf2 activator-1 has the potential for the treatment of COPD and other respiratory diseases, including asthma, Acute Lung Injury (ALI), Acute Respiratory Distress Syndrome (ARDS) and pulmonary fibrosis (extracted from patent WO2018109647A1).

2230697-41-1

C30H34N4O6S

578.68

Nrf2 activator-1;Nrf2 activator-1

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years